Oxygen Therapy Equipment Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product Type (Oxygen Source Equipment {Oxygen Cylinders, Oxygen Concentrators, Liquid Oxygen Devices, Others}, Oxygen Delivery Devices {Oxygen Masks, Nasal Cannula, Non-Rebreather Masks, Others}), By Mobility (Stationary, Portable), By Application (COPD, Lung Cancer, Pneumonia, COVID-19, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Homecare, Others), By Region & Competition, 2020-2030F

Market Overview

Global Oxygen Therapy Equipment market was valued at USD 12.31 Billion in 2024 and is expected to reach USD 17.70 Billion by 2030 with a CAGR of 6.20%. Oxygen therapy is a treatment modality for individuals requiring adequate oxygen levels. It is commonly utilized to manage conditions like asthma, Chronic Obstructive Pulmonary Disease (COPD), sleep apnea, and others where there is an insufficiency in oxygen supply to patients. Depending on their specific needs, patients can access various types of oxygen therapy such as oxygen concentrators, liquid oxygen, and hyperbaric oxygen therapy. Oxygen therapy, as a medical intervention, employs oxygen gas to deliver acute or chronic patient care, as it plays a crucial role in diverse cell metabolism and optimal physiological function through tissue oxygenation.

When blood oxygen levels are low, oxygen therapy is employed. It can be administered through different methods, ranging from nasal to hyperbaric oxygen in a closed environment. The respiratory system, consisting of the lungs, nasal passages, and windpipe, facilitates the process of respiration. Air enters the body through the nose or mouth and travels through the windpipe to the lungs via the bronchi. Oxygen therapy equipment is a reliable device that offers a secure supply of oxygen-enriched air. These devices effectively filter room air, removing dust, bacteria, and other particulates to ensure optimal purity.

Key Market Drivers

Surge In the Latest Oxygen Therapy Solutions

The demand for the most minor, durable portable oxygen solutions is rising. Patients are increasingly seeking oxygen therapy options that are not only compact and long-lasting but also easy to carry. This preference arises from their desire to avoid the burden of lugging around a heavy and cumbersome oxygen device. Fortunately, recent years have witnessed significant advancements in oxygen-conserving methods and lithium-ion battery technology, particularly in terms of battery life improvement.

The latest versions of portable oxygen concentrators weigh a mere 5-7 pounds. These lightweight devices can provide oxygen therapy for extended periods, ranging from 8 to 13 hours, depending on the litre flow settings chosen by each patient, after a single battery charge. The focus of manufacturers has also shifted towards developing silent compressor motors for these concentrators, thereby reducing noise pollution in small and confined spaces.

Moreover, the effective utilization of dosing technology has enabled portable oxygen concentrator manufacturers to enhance their products' performance features. This, in turn, has resulted in current designs that offer a longer lifespan beyond occasional use, making them more reliable and durable for a consistent five-year cycle. With these advancements and improvements, patients can now enjoy the benefits of portable oxygen therapy without compromising on convenience, reliability, and longevity.

Increase in Tobacco Smoking

The increase in tobacco smoking is expected to drive up the demand for oxygen therapy equipment, as smoking-related health issues continue to be a major public health concern worldwide. Tobacco use is responsible for over 8 million deaths annually, including approximately 1.3 million non-smokers who die due to exposure to second-hand smoke. Notably, nearly 80% of the world’s 1.3 billion tobacco users reside in low- and middle-income countries, highlighting a significant public health and economic burden in regions with limited healthcare infrastructure and fewer regulatory controls. Smoking is a leading cause of various respiratory conditions, including chronic obstructive pulmonary disease (COPD) and lung cancer, which often necessitate oxygen therapy as part of the treatment and management plan. Tobacco smoking remains the primary driver of COPD prevalence in high-income markets, with studies indicating it accounts for over 70% of diagnosed cases. This strong correlation underscores the direct impact of smoking behavior on chronic respiratory disease burdens, placing increased pressure on healthcare systems and creating sustained demand for long-term oxygen therapy and pulmonary care solutions in these regions.

COPD, a progressive lung disease commonly linked to smoking, can severely impact a person's ability to breathe efficiently. As the condition worsens, individuals often experience oxygen deficiency, requiring supplemental oxygen therapy to maintain adequate blood oxygen levels. With the rising number of COPD cases due to smoking, there is a growing need for oxygen concentrators, portable oxygen tanks, and other oxygen delivery systems to improve the quality of life for affected individuals.

Smoking is a significant risk factor for lung cancer, and patients undergoing lung cancer treatments may also require oxygen therapy to manage symptoms and side effects. Lung cancer continues to represent a critical global health burden, with tobacco smoking identified as the leading causative factor. In 2022 alone, approximately 2.48 million new cases were reported worldwide, resulting in an estimated 1.82 million deaths. These figures reflect not only the aggressive nature of the disease but also the substantial healthcare costs and resource allocation required for diagnosis, treatment, and palliative care particularly in regions with high smoking prevalence. As the global incidence of lung cancer continues to rise due to smoking habits, the demand for oxygen therapy equipment, such as oxygen concentrators and oxygen masks, is likely to increase in tandem. The increase in tobacco smoking-related health conditions underscores the vital role that oxygen therapy equipment plays in managing and improving the lives of affected individuals. As smoking-related respiratory diseases continue to pose a significant global health challenge, the demand for oxygen therapy equipment is expected to grow, necessitating ongoing advancements and innovations in this critical medical field.

Rising Prevalence of Respiratory Diseases

The rising prevalence of respiratory diseases is expected to drive a significant increase in the demand for oxygen therapy equipment, marking a crucial facet of modern healthcare. Respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, pneumonia, and interstitial lung diseases are on the rise globally, and they often necessitate the use of oxygen therapy to manage symptoms and improve patients' quality of life.

Chronic respiratory conditions like COPD have become a major public health concern, particularly due to factors such as air pollution, smoking, and an aging population. Patients with COPD often experience difficulty in breathing and require supplemental oxygen to maintain adequate blood oxygen levels. This growing demographic has led to an increased demand for oxygen concentrators, portable oxygen tanks, and other oxygen delivery systems.

Asthma, another common respiratory ailment, affects millions of people worldwide, and severe asthma attacks can lead to oxygen deprivation. Oxygen therapy is often crucial in stabilizing patients during acute asthma exacerbations, further contributing to the demand for oxygen-related equipment. The COVID-19 pandemic also highlighted the importance of oxygen therapy equipment as hospitals worldwide faced surges in patients with severe respiratory symptoms. This emphasized the necessity for having adequate oxygen infrastructure in healthcare facilities, further underscoring the demand for oxygen concentrators and ventilators.

Furthermore, as healthcare trends shift towards home-based care and telemedicine, the demand for portable and user-friendly oxygen therapy equipment for patients managing chronic respiratory conditions at home is increasing.

Technological Advancement in Oxygen Therapy

Technological advancements in the field of oxygen therapy are poised to revolutionize the healthcare industry, driving an unprecedented surge in the demand for oxygen therapy equipment. These innovations are not only improving the efficacy of treatment but also enhancing patient comfort and accessibility, thus reshaping the landscape of respiratory care.

One significant development is the proliferation of portable oxygen concentrators (POCs) that offer patients the freedom to receive oxygen therapy while on the move. These lightweight and compact devices are equipped with advanced battery technology, ensuring extended runtime, and they allow patients to maintain an active lifestyle, contributing to an increased quality of life. As the aging population continues to grow, the demand for POCs is expected to soar, as they enable seniors to remain independent and engaged in their communities.

Moreover, telemedicine and remote monitoring solutions have emerged as powerful tools in oxygen therapy management. The integration of smart sensors and wireless connectivity enables healthcare professionals to remotely track patients' oxygen levels, adjust treatment plans in real-time, and provide immediate support when necessary. This not only enhances the overall patient experience but also reduces the burden on healthcare facilities and staff.

Download Free Sample Report

Key Market Challenges

Stringent Regulatory Guidelines

Stringent regulatory guidelines in the healthcare industry have the potential to significantly decrease the demand for oxygen therapy equipment. While regulations are essential for ensuring patient safety and treatment efficacy, an excessively complex or burdensome regulatory environment can create obstacles that hinder innovation, drive up costs, and limit market access for manufacturers and healthcare providers. Rigorous regulatory processes can slow down the introduction of new and improved oxygen therapy equipment to the market. This delay can have serious consequences, as patients may miss out on potentially more effective treatments or innovations that enhance their quality of life. Healthcare providers may also be discouraged from adopting new technologies due to the uncertainties and complexities associated with regulatory approval, further stifling demand.

Additionally, stringent guidelines can lead to a limited selection of available equipment, reducing competition and innovation within the industry. This lack of variety can result in fewer options for patients and healthcare professionals, making it harder to find solutions that best meet individual needs. While regulatory guidelines are crucial for ensuring patient safety and treatment effectiveness, excessively stringent regulations can create barriers that diminish the demand for oxygen therapy equipment. Striking the right balance between regulation and innovation is essential to ensure that patients have access to the most advanced and affordable respiratory care solutions.

Frequent Adverse Effects

The market expansion for oxygen treatment is being constrained by their unfavorable side effects, which, when used therapeutically, include skin irritation and nasal dryness. Dryness of the nose and skin irritation are two of the most typical side effects of oxygen therapy. The cannula may rub against the skin and create irritation.

Moreover, prolonged exposure to high oxygen concentrations can lead to an increased risk of oxygen toxicity, which can seriously harm not only the lungs but also other organ systems. Inappropriate or excessive supplemental oxygen can result in oxygen toxicity, causing detrimental effects on lung function and overall health. This can potentially lead to lung injury and impair the body's ability to effectively exchange gases.

Additionally, the range of lung ailments that can be induced by oxygen therapy extends beyond minor tracheobronchitis to include widespread alveolar damage. The excessive production of free radicals due to long-term exposure to high oxygen concentrations can further contribute to lung injury and hinder the overall effectiveness of oxygen therapy. Considering these factors, it becomes evident that the presence of such side effects and potential risks associated with oxygen therapy may pose challenges in the expansion of the oxygen therapy equipment market.

Key Market Trends

Technology Advancements in Therapeutic Equipment

Due to the significant increase in the number of individuals with respiratory conditions who rely on oxygen therapy devices (OTD), healthcare facilities are facing immense pressure to effectively manage patients who require constant OTD support. This growing demand is driving the market for oxygen therapy solutions. As wearable technology continues to advance, with notable improvements in Photoplethysmography (PPG) sensors and wireless 5G connectivity, it is expected that the trend of digital health data transfer for oxygen therapy monitoring will experience rapid growth.

PPG, a non-invasive device, accurately measures volumetric fluctuations in blood circulation by utilizing a light source and a photodetector placed on the skin's surface. Wearable PPG sensors can be comfortably accommodated on specific body parts such as fingertips, earlobes, and the forehead. Moreover, with the increasing utilization and adoption of remote patient monitoring systems, patients are becoming more actively engaged in their own care, thanks to proper instruction in the use of these systems. These advancements and patient involvement hold promising prospects for the market's growth and profitability.

Advanced Portable Oxygen Solutions

Portable oxygen concentrators (POCs) and lightweight, wearable devices will continue to evolve. These innovations will allow patients to receive oxygen therapy while maintaining an active lifestyle and even traveling, contributing to a better quality of life. POCs will continue to become smaller and lighter, making them highly portable. These devices will be easier to carry in backpacks or even wear as discreet accessories. Patients will have the freedom to move around without the burden of bulky equipment.

Battery technology will advance, providing POCs with longer runtime. This means patients can go longer periods without needing to recharge or replace their batteries, making travel and outdoor activities more practical. POCs will feature wireless connectivity options, allowing for remote monitoring by healthcare providers and caregivers. Real-time data on oxygen levels and usage patterns can be transmitted, enabling timely adjustments to treatment plans and better support. These advancements will collectively empower patients to lead more active and fulfilling lives while managing their oxygen therapy needs. With greater portability, convenience, and connectivity, patients will be better equipped to maintain an active lifestyle, travel, and participate in a wide range of activities, ultimately contributing to an improved quality of life for individuals with respiratory conditions.

Segmental Insights

Mobility Insights

Based on the mobility segment, the portable segment dominate the Global oxygen therapy equipment market. This is primarily due to the fact that a significant number of patients receiving treatment are confined to beds, thus making the fixed oxygen therapy equipment market the key driver and contributor to maximum market revenue throughout the projection period.

The expansion of this category can be attributed to several factors, including a rising population base, favourable reimbursement policies, and a low mobility profile of patients. As a result, there is an increased demand for long-term oxygen therapy (LTOT) equipment in residential settings, which is expected to further boost the overall demand for oxygen therapy equipment over the projected period. The utilization of LTOT equipment in residential settings not only provides enhanced convenience and comfort for patients but also contributes to the overall improvement in their quality of life.

Application Insights

Based on the Application, The Chronic Obstructive Pulmonary Disorder (COPD) segment emerges as the fastest growing segment in the Global oxygen therapy equipment market. According to data from the World Health Organization (WHO), an estimated 65 million people globally are currently diagnosed with moderate to severe chronic obstructive pulmonary disease (COPD). This figure underscores a significant addressable patient population for advanced respiratory care solutions, particularly in markets where disease management is shifting toward long-term, home-based oxygen therapy. This alarming statistic highlights the urgent need for effective COPD therapy and creates a significant clinical demand in the market, which in turn contributes to the growth of companies operating in this domain. With the rising prevalence of COPD, there is an increasing focus on developing innovative treatment solutions to address this chronic respiratory disorder and improve the quality of life for affected individuals.

Download Free Sample Report

Regional Insights

Based on region, North America region emerged as the largest market in the global oxygen therapy equipment market. The region’s dominance is primarily anchored by the United States, which accounts for the majority of the market share due to its early adoption of home healthcare models, widespread use of portable oxygen concentrators, and the presence of leading global manufacturers.

The prevalence of chronic respiratory diseases such as COPD and sleep apnea remains a major demand driver, particularly among the aging population. Additionally, the COVID-19 pandemic significantly accelerated the uptake of oxygen therapy devices, both in clinical and home settings, reinforcing the need for scalable respiratory support infrastructure. North America benefits from robust insurance coverage and Medicare policies that subsidize oxygen therapy equipment, thus enhancing patient access and reducing out-of-pocket expenses factors that are less developed in many other regions.

The market is characterized by strong competition and rapid innovation, with companies investing in portable, lightweight, and connected oxygen delivery systems to cater to the shift toward home-based care. Regulatory clarity from agencies like the FDA further enables faster product approvals and commercialization. The region also serves as a key hub for R&D, partnerships, and acquisitions, making it a strategic base for both domestic and international players seeking to scale operations in the respiratory care segment.

Recent Developments

• In January 2025- Caire has officially launched its latest stationary oxygen concentrator, the IntenOxy 5, now commercially available across the United States and Puerto Rico. The company has also confirmed plans to extend availability to the Canadian market in the near term, signaling a broader North American rollout strategy for the new device.
• In October 2024, Inogen, Inc., a medical technology company specializing in home-based respiratory solutions, has initiated the U.S. market launch of its latest innovation the Inogen® Rove 4™ Portable Oxygen Concentrator. This rollout marks a strategic expansion of the company’s product portfolio aimed at enhancing mobility and independence for patients requiring oxygen therapy.
• In April 2024, Dynarex Corporation, a key player in the durable medical equipment and disposable healthcare products sector, has announced the expansion of its Dynarex Resp-O2™ respiratory therapy portfolio with the introduction of a new range of portable solutions. The updated line now features mobile equipment for oxygen delivery, suction care, and nebulization therapy, reinforcing the company’s strategic focus on versatile, patient-centered respiratory care across clinical and home settings.

Key Market Players

• Allied Healthcare Products, Inc.
• CAIRE Inc.
• DeVilbiss Healthcare
• Fisher & Paykel Healthcare Limited
• Inogen Inc.
• Invacare Corporation
• Koninklijke Philips N.V.,
• Smith’s Medical, Inc.
• Taiyo Nippon Sanso Corporation
• Linde Healthcare

Report Scope:

In this report, the Global Oxygen Therapy Equipment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Oxygen Therapy Equipment Market, By Product Type:

o   Oxygen Source Equipment

o   Oxygen Delivery Devices

• Oxygen Therapy Equipment Market, By Mobility:

o   Stationary

o   Portable

• Oxygen Therapy Equipment Market, By Application:

o   COPD

o   Lung Cancer

o   Pneumonia

o   COVID-19

o   Others

• Oxygen Therapy Equipment Market, By End User:

o   Hospitals & Clinics

o   Ambulatory Care Centres

o   Homecare

o   Others

• Oxygen Therapy Equipment Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oxygen Therapy Equipment Market.

Available Customizations:

Global Oxygen Therapy Equipment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Oxygen Therapy Equipment Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]